Lauren Hackett named deputy director of administration at Albert Einstein Cancer Center

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Lauren Hackett was named deputy director of administration of Albert Einstein Cancer Center and associate vice president of cancer medicine at Montefiore Medicine. 

Hackett, who is currently the chief operating officer at the Allen Institute, will assume these roles in August 2021.  

At AECC, Hackett will have oversight and authority over the administrative team and structure, running all aspects of its operations. A key part of her role is partnering with the senior leaders at AECC, Einstein, and Montefiore to align and implement strategic priorities across its cancer enterprise.  

As COO at the Allen Institute, a private, non-profit research institute, she led the institute through the COVID-19 pandemic and co-developed the institute’s diversity, equity, and inclusion initiative. She also partnered with colleagues to integrate scientific strategy and planning efforts throughout administration and operations teams across the institute.  

Table of Contents

YOU MAY BE INTERESTED IN

In April 2025, announcements from the two most influential biomedical agencies in the US, the FDA and the NIH, declared that both will seek to reduce and minimize animal-based testing and experimentation. These declarations sparked joy in some circles, and deep concern in others that was reflected in a 28% fall in the share price of Charles River Labs (NYSE: NYSE:CRL). 
Over the past three decades, cancer genetics has transformed precision oncology. Germline testing has advanced from single-gene Sanger sequencing to parallel sequencing of hundreds of genes, while tumor (somatic) testing has expanded with the rise of targeted therapies based on point mutations, copy number changes and other alterations. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login